Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)
USD 25.28
(0.13%)
USD 25.28
(0.13%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 89.97 Million USD | 46.79% |
| 2022 | 61.29 Million USD | 16.97% |
| 2021 | 52.39 Million USD | 55.67% |
| 2020 | 33.66 Million USD | -4.32% |
| 2019 | 35.17 Million USD | 17.0% |
| 2018 | 30.06 Million USD | 18.23% |
| 2017 | 25.43 Million USD | -1.0% |
| 2016 | 25.69 Million USD | 32.89% |
| 2015 | 19.33 Million USD | 80.43% |
| 2014 | 10.71 Million USD | 39.2% |
| 2013 | 7.69 Million USD | 79.88% |
| 2012 | 4.27 Million USD | 355.57% |
| 2011 | 939.22 Thousand USD | -62.47% |
| 2010 | 2.5 Million USD | -45.17% |
| 2009 | 4.56 Million USD | 21.83% |
| 2008 | 3.74 Million USD | 31.02% |
| 2007 | 2.85 Million USD | 6088.35% |
| 2006 | 46.2 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 34.87 Million USD | 12.62% |
| 2024 Q1 | 30.96 Million USD | 4.79% |
| 2023 Q1 | 16.62 Million USD | 4.27% |
| 2023 Q2 | 21.11 Million USD | 27.05% |
| 2023 Q4 | 29.54 Million USD | 31.59% |
| 2023 FY | 89.97 Million USD | 46.79% |
| 2023 Q3 | 22.45 Million USD | 6.33% |
| 2022 Q3 | 16.19 Million USD | 7.27% |
| 2022 Q4 | 15.94 Million USD | -1.57% |
| 2022 Q1 | 14.05 Million USD | -15.4% |
| 2022 Q2 | 15.09 Million USD | 7.42% |
| 2022 FY | 61.29 Million USD | 16.97% |
| 2021 FY | 52.39 Million USD | 55.67% |
| 2021 Q2 | 9.54 Million USD | 9.05% |
| 2021 Q1 | 8.75 Million USD | 9.01% |
| 2021 Q3 | 17.48 Million USD | 83.09% |
| 2021 Q4 | 16.61 Million USD | -4.96% |
| 2020 Q4 | 8.03 Million USD | -11.79% |
| 2020 FY | 33.66 Million USD | -4.32% |
| 2020 Q2 | 7.7 Million USD | -12.65% |
| 2020 Q1 | 8.81 Million USD | 8.6% |
| 2020 Q3 | 9.1 Million USD | 18.21% |
| 2019 Q1 | 8.94 Million USD | -5.26% |
| 2019 FY | 35.17 Million USD | 17.0% |
| 2019 Q2 | 9.05 Million USD | 1.23% |
| 2019 Q3 | 9.05 Million USD | -0.07% |
| 2019 Q4 | 8.12 Million USD | -10.29% |
| 2018 Q2 | 6.85 Million USD | 4.2% |
| 2018 Q1 | 6.57 Million USD | 9.02% |
| 2018 FY | 30.06 Million USD | 18.23% |
| 2018 Q4 | 9.44 Million USD | 31.24% |
| 2018 Q3 | 7.19 Million USD | 5.05% |
| 2017 Q2 | 6.58 Million USD | -5.52% |
| 2017 Q1 | 6.97 Million USD | 11.89% |
| 2017 Q4 | 6.03 Million USD | 3.2% |
| 2017 Q3 | 5.84 Million USD | -11.27% |
| 2017 FY | 25.43 Million USD | -1.0% |
| 2016 Q3 | 6.83 Million USD | 1.31% |
| 2016 Q2 | 6.74 Million USD | 14.56% |
| 2016 Q1 | 5.88 Million USD | -5.84% |
| 2016 Q4 | 6.23 Million USD | -8.8% |
| 2016 FY | 25.69 Million USD | 32.89% |
| 2015 Q3 | 5.01 Million USD | 13.92% |
| 2015 FY | 19.33 Million USD | 80.43% |
| 2015 Q4 | 6.25 Million USD | 24.77% |
| 2015 Q2 | 4.39 Million USD | 19.74% |
| 2015 Q1 | 3.67 Million USD | 25.67% |
| 2014 FY | 10.71 Million USD | 39.2% |
| 2014 Q1 | 2.33 Million USD | 23.26% |
| 2014 Q2 | 2.79 Million USD | 19.56% |
| 2014 Q3 | 2.66 Million USD | -4.78% |
| 2014 Q4 | 2.92 Million USD | 9.86% |
| 2013 Q4 | 1.89 Million USD | -9.39% |
| 2013 Q3 | 2.09 Million USD | -6.32% |
| 2013 Q2 | 2.23 Million USD | 51.42% |
| 2013 Q1 | 1.47 Million USD | 1.13% |
| 2013 FY | 7.69 Million USD | 79.88% |
| 2012 Q4 | 1.45 Million USD | 16.69% |
| 2012 Q1 | 451.91 Thousand USD | 44.32% |
| 2012 Q2 | 1.11 Million USD | 147.45% |
| 2012 Q3 | 1.25 Million USD | 11.78% |
| 2012 FY | 4.27 Million USD | 355.57% |
| 2011 Q3 | 66.49 Thousand USD | -54.38% |
| 2011 FY | 939.22 Thousand USD | -62.47% |
| 2011 Q2 | 145.76 Thousand USD | -64.78% |
| 2011 Q1 | 413.82 Thousand USD | 1.61% |
| 2011 Q4 | 313.14 Thousand USD | 370.92% |
| 2010 Q1 | 870.74 Thousand USD | 12.13% |
| 2010 FY | 2.5 Million USD | -45.17% |
| 2010 Q2 | 496.76 Thousand USD | -42.95% |
| 2010 Q4 | 407.28 Thousand USD | -44.04% |
| 2010 Q3 | 727.77 Thousand USD | 46.5% |
| 2009 Q2 | 1.23 Million USD | -24.43% |
| 2009 FY | 4.56 Million USD | 21.83% |
| 2009 Q4 | 776.52 Thousand USD | -16.43% |
| 2009 Q3 | 929.23 Thousand USD | -24.47% |
| 2009 Q1 | 1.62 Million USD | 68.82% |
| 2008 Q2 | 1.28 Million USD | 91.98% |
| 2008 Q3 | -834.67 Thousand USD | -165.19% |
| 2008 Q4 | 964.35 Thousand USD | 215.54% |
| 2008 FY | 3.74 Million USD | 31.02% |
| 2008 Q1 | 666.95 Thousand USD | -57.08% |
| 2007 FY | 2.85 Million USD | 6088.35% |
| 2007 Q3 | -969.14 Thousand USD | -87489.0% |
| 2007 Q1 | 1897.00 USD | -34.65% |
| 2007 Q2 | 1109.00 USD | -41.54% |
| 2007 Q4 | 1.55 Million USD | 260.33% |
| 2006 Q4 | 2903.00 USD | -62.46% |
| 2006 FY | 46.2 Thousand USD | 0.0% |
| 2006 Q3 | 7733.00 USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 13.47 Million USD | -567.579% |
| China Jo-Jo Drugstores, Inc. | 34.64 Million USD | -159.714% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 90.12 Million USD | 0.165% |
| Leafly Holdings, Inc. | 44.5 Million USD | -102.177% |
| LifeMD, Inc. | 148.13 Million USD | 39.263% |
| LifeMD, Inc. | 148.13 Million USD | 39.263% |
| TRxADE HEALTH, Inc. | 9.86 Million USD | -812.351% |
| PetMed Express, Inc. | 86.81 Million USD | -3.644% |
| Walgreens Boots Alliance, Inc. | 40.6 Billion USD | 99.778% |